# naloxone hydrochloride

NDC: 43066-142
Generic name: naloxone hydrochloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20250603

FDA application: ANDA214785

## Active ingredients

- NALOXONE HYDROCHLORIDE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-142"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-142
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=48137634-91d7-41e3-b54b-e4321d69668a